These findings provide that RASAL2-AS1 targets METTL14 to regulate the LIS1 signaling pathway in vivo, offering valuable insights into the role of this interaction in HNSCC progression. This evidence concerns the gene PAFAH1B1 and head and neck squamous cell carcinoma.